Efficacy of the vaccination in inflammatory bowel disease

World Journal of Gastroenterology

Volumn 19, Issue 9, 2013, Pages 1349-1353

  Carrera, Elisa ^a   Manzano, Rebeca ^b   Garrido, Elena ^c  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b Hospital del Sureste   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Efficacy; Hepatitis B vaccines; Immunization; Immunosuppressive medications; Infections; Inflammatory bowel disease; Influenza vaccines; Pneumococcal vaccines; Tetanus vaccines; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; CLINICAL PRACTICE; ENTERITIS; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INFLUENZA; NONHUMAN; TETANUS; VACCINATION;

EID: 84875108314     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i9.1349     Document Type: Article

References (52)

1. Deutsch DE, Olson AD, Kraker S, Dickinson CJ. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr 1995; 20: 351-353. [PMID: 7608833 DOI: 10.1097/0000517 6-199504000-00016]
2. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004; 99: 2503-2504. [PMID: 15571606 DOI: 10.1111/j.1572-0241.2004.41389_7.x]
3. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001; 7: 327. [PMID: 11720324]
4. Foster KJ, Devitt N, Gallagher PJ, Abbott RM. Overwhelming pneumococcal septicaemia in a patient with ulcerative colitis and splenic atrophy. Gut 1982; 23: 630-632. [PMID: 7084807]
5. Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004; 53: 1363-1365. [PMID: 15306601]
6. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993; 42: 1-18. [PMID: 8474421]
7. Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 677-692. [PMID: 15472534 DOI: 10.1097/00054725-20040900000028]
8. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009; 3: 47-91. [PMID: 21172250 DOI: 10.1016/j.crohns.2009.02.01]
9. Esteve M, Loras C, García-Planella E. Inflammatory bowel disease in travelers: choosing the right vaccines and checkups. World J Gastroenterol 2011; 17: 2708-2714. [PMID: 21734778 DOI: 10.3748/wjg.v17.i22.2708]
10. Yeung JH, Goodman KJ, Fedorak RN. Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis 2012; 18: 34-40. [PMID: 21337671 DOI: 10.1002/ibd.21668)]
11. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis 2011; 17: 2536-2540. [PMID: 21538710]
12. Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA. Patients with inflammatory bowel disease are at risk for vaccinepreventable illnesses. Am J Gastroenterol 2006; 101: 1834-1840. [PMID: 16817843 DOI: 10.1111/j.1572-0241.2006.00646.x]
13. Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol 2009; 104: 57-63. [PMID: 19098850 DOI: 10.1038/ajg.2008.4]
14. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010; 105: 1231-1238. [PMID: 20104218 DOI: 10.1038/ajg.2009.733]
15. Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG. A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis 2007; 196: 1304-1312. [PMID: 17922394 DOI: 10.1086/522428]
16. WHO Publication. Hepatitis B vaccines: WHO position paper--recommendations. Vaccine 2010; 28: 589-590. [PMID: 19896455 DOI: 10.1016/j.vaccine.2009.10.110]
17. Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 623-625. [PMID: 12079904 DOI: 10.1136/ard.61.7.623]
18. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Flik J. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig 1992; 70: 585-587. [PMID: 1392427]
19. Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab. Am J Gastroenterol 2012; 107: 133-138. [PMID: 21876562 DOI: 10.1038/ajg.2011.295.]
20. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis 2009; 15: 1410-1416. [PMID: 19462435 DOI: 10.1002/ibd.20943]
21. Bruguera M, Cremades M, Salinas R, Costa J, Grau M, Sans J. Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 1992; 14: 27-30. [PMID: 1532609]
22. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008; 67: 713-716. [PMID: 17965123]
23. Coates T, Wilson R, Patrick G, André F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001; 23: 392-403. [PMID: 11318074]
24. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55: 1-33; quiz CE1-4. [PMID: 17159833]
25. Vida Pérez L, Gómez Camacho F, García Sánchez V, Iglesias Flores EM, Castillo Molina L, Cerezo Ruiz A, Casáis Juanena L, De Dios Vega JF. Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease. Med Clin (Barc) 2009; 132: 331-335. [PMID: 19268981 DOI: 10.1016/j.medcli.2008.07.013]
26. Chevaux JB, Bigard MA, Bensenane M, Oussalah A, Jarlot S, Belle A, Nani A, Bronowicki JP, Peyrin-Biroulet L. Inflammatory bowel disease and hepatitis B and C. Gastroenterol Clin Biol 2009; 33: 1082-1093. [PMID: 19896313 DOI: 10.1016/j.gcb.2009.03.021]
27. Shouval D. Hepatitis B vaccines. J Hepatol 2003; 39 Suppl 1: S70-S76. [PMID: 14708681 DOI: 10.1016/S0168-8278(03)00152-1]
28. Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 619-633. [PMID: 21416659 DOI: 10.1111/j.1365-2036.2010.04570.x]
29. Hall AJ. Boosters for hepatitis B vaccination? Need for an evidence-based policy. Hepatology 2010; 51: 1485-1486. [PMID: 20432250 DOI: 10.1002/hep.23674]
30. Altunöz ME, Senateş E, Yeşil A, Calhan T, Ovünç AO. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. Dig Dis Sci 2012; 57: 1039-1044. [PMID: 22147248 DOI: 10.1007/s10620-011-1980-8]
31. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997; 336: 196-204. [PMID: 8988900]
32. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med 2010; 152: 36-39. [PMID: 20048270 DOI: 10.10 59/0003-4819-152-1-201001050-00008]
33. Choudhury SA, Peters VB. Responses to hepatitis B vaccine boosters in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1995; 14: 65-67. [PMID: 7715995]
34. Fonseca MO, Pang LW, de Paula Cavalheiro N, Barone AA, Heloisa Lopes M. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine 2005; 23: 2902-2908. [PMID: 15780739 DOI: 10.1016/j.vaccine.2004.11.057]
35. Rey D, Krantz V, Partisani M, Schmitt MP, Meyer P, Libbrecht E, Wendling MJ, Vetter D, Nicolle M, Kempf-Durepaire G, Lang JM. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 2000; 18: 1161-1165. [PMID: 10649616]
36. Chaparro M, Villagrasa JR, Rodriguez Nogueiras A, Gisbert JP. Immune response to hepatitis B vaccination in patients with inflammatory bowel disease. Gastroenterology 2010; 138: S197 [DOI: 10.1016/S0016-5085(10)60891-8]
37. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54: 1-40. [PMID: 16086456]
38. Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1994; 21: 1203-1206. [PMID: 7966058]
39. Malleson PN, Tekano JL, Scheifele DW, Weber JM. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol 1993; 20: 1769-1773. [PMID: 7848389]
40. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczyńska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000; 18: 3280-3286. [PMID: 10869773]
41. Agarwal N, Ollington K, Kaneshiro M, Frenck R, Melmed GY. Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review. Vaccine 2012; 30: 1413-1424. [PMID: 22197580]
42. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007; 5: 851-856. [PMID: 17544875 DOI: 10.1016/j.cgh.2007.02.035]
43. Lu Y, Jacobson DL, Ashworth LA, Grand RJ, Meyer AL, McNeal MM, Gregas MC, Burchett SK, Bousvaros A. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009; 104: 444-453. [PMID: 19174786 DOI: 10.1038/ajg.2008.120]
44. Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, Malter L, Abreu M, Ullman T, Guzner-Gur H, Halpern Z, Mayer L. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis 2012; 18: 261-268. [PMID: 21438101 DOI: 10.1002/ibd.21688)]
45. Melmed GY, Agarwal N, Frenck RW, Ippoliti AF, Ibanez P, Papadakis KA, Simpson P, Barolet-Garcia C, Ward J, Targan SR, Vasiliauskas EA. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010; 105: 148-154. [PMID: 19755964 DOI: 10.1038/ajg.2009.523]
46. Nielsen HJ, Mortensen T, Holten-Andersen M, Brünner N, Sørensen S, Rask-Madsen J. Increased levels of specific leukocyteand platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol 2001; 36: 265-269. [PMID: 11305513]
47. Brogan MD, Shanahan F, Oliver M, Stevens RH, Targan SR. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol 1987; 24: 69-74. [PMID: 3437440]
48. Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29: 2555-2557. [PMID: 12465151]
49. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 2005; 45: 831-837. [PMID: 16007602 DOI: 10.1002/pbc.20470]
50. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539. [PMID: 17256718 DOI: 10.1002/hep.21513]
51. Bertino JS, Tirrell P, Greenberg RN, Keyserling HL, Poland GA, Gump D, Kumar ML, Ramsey K. A comparative trial of standard or high-dose S subunit recombinant hepatitis B vaccine versus a vaccine containing S subunit, pre-S1, and pre-S2 particles for revaccination of healthy adult nonresponders. J Infect Dis 1997; 175: 678-681. [PMID: 9041342]
52. Cardell K, Akerlind B, Sällberg M, Frydén A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis 2008; 198: 299-304. [PMID: 18544037 DOI: 10.1086/589722]